Pieris Pharmaceuticals stock is up on Wednesday as PIRS investors learn of the company preparing for a merger with Palvella Therapeutics. More
Articles
Get Your Money Out of These 3 Clean Energy Stocks by 2025
Are you a clean energy investor? These three clean energy stocks could tank soon. Discover why you should abandon them by 2025. More
DSDVY Stock Earnings: DSV Beats EPS, Beats Revenue for Q2 2024
DSDVY stock results show that DSV beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
OTLY Stock Earnings: Oatly Group Beats EPS, Beats Revenue for Q2 2024
OTLY stock results show that Oatly Group beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
TSEM Stock Earnings: Tower Semiconductor Beats EPS, Beats Revenue for Q2 2024
TSEM stock results show that Tower Semiconductor beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
IP Stock Earnings: International Paper Beats EPS, Misses Revenue for Q2 2024
IP stock results show that International Paper beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
CME Stock Earnings: CME Gr Beats EPS, Beats Revenue for Q2 2024
CME stock results show that CME Gr beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
